$1.35
0.064.65%
At close: -
$1.30
-0.05-3.70%
After Hours: Dec 20, 9:20 AM EDT
Evogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evogene using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-21 | $-1.31 | $-1.01 | -29.7 % |
Jun 2024 | 2024-08-22 | $-1.06 | $-1.20 | 11.7 % |
Mar 2024 | 2024-05-23 | $-0.80 | $-0.90 | 11.1 % |
Dec 2023 | 2024-03-07 | $-1.30 | $-1.40 | 7.14 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-21 | $1.80M | $2.85M | -37.0 % |
Jun 2024 | 2024-08-22 | $914.00K | $800.00K | 14.2 % |
Mar 2024 | 2024-05-23 | $4.19M | $3.50M | 19.7 % |
Dec 2023 | 2024-03-07 | $578.00K | $910.00K | -36.5 % |
Evogene (EVGN) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 21, 2024 for Q3.
The Actual EPS was $-1.31, which missed the estimate of $-1.01.
The Actual Revenue was $1.8M, which missed the estimate of $2.9M.
Browse earnings estimates, EPS, and revenue on all stocks.